DPDoctor's PassportEducation
Obstetrics and gynaecology indexPassport
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Textbook/Obstetrics and gynaecology/Pregnancy testing in reproductive-age presentations
Full textbookMLAMSRAFoundationGP

Pregnancy testing in reproductive-age presentations

Use consented pregnancy testing according to pregnancy potential and clinical consequence, interpret early or persistent hCG safely, and escalate pain, bleeding or instability without false reassurance from a single result.

26 min full readUK scopeSources checked 27 Aug 2026Clinical review pending
!
Treat suspected ectopic pregnancy as time-critical

Collapse, syncope, shoulder-tip pain, peritonism, severe unilateral pelvic pain or significant bleeding with a positive, unknown or very early pregnancy status can indicate ruptured ectopic pregnancy.

Action: Start ABCDE, obtain urgent gynaecology support and bedside pregnancy testing or serum hCG in parallel, but do not wait for laboratory confirmation before resuscitation, blood preparation and definitive imaging or surgery.

Open the sections you need. The overview is shown first.
01Purpose and principlesWhat the assessment is for and the core concepts behind it.

Pregnancy testing is a clinical intervention with consent and consequences. Ask whether the person has a uterus, whether sperm exposure could have occurred, last normal menstrual period, cycle reliability, contraception, fertility treatment, recent pregnancy and current symptoms. Use inclusive language and a private conversation. Contraception reduces probability but does not make pregnancy impossible, and amenorrhoea may be absent with irregular cycles, postpartum states or hormonal methods. Explain why testing is recommended and what a positive, negative or indeterminate result would change.

Urine assays detect hCG above a device-specific threshold. NHS guidance describes testing as most reliable from the first missed period, or at least 21 days after the last unprotected intercourse when the next period is unknown. Early implantation timing varies, so a correctly performed test can still be negative before sufficient urinary hCG accumulates. Dilute urine, reading outside the stated window or an expired device also reduces reliability. Repeat after an appropriate interval, use first-morning urine or request quantitative serum hCG when immediate management depends on greater sensitivity.

A positive test answers only whether hCG is detected. It does not establish that the pregnancy is intrauterine, currently viable or of the expected gestation. hCG may persist after birth, miscarriage or termination and can follow exogenous fertility treatment; rarely trophoblastic or other hCG-producing disease contributes. Review dates and clinical context before labelling a new pregnancy. When pain or bleeding is present, use transvaginal ultrasound and clinical assessment rather than an hCG threshold alone.

Pregnancy of unknown location means a positive test without an intrauterine or ectopic pregnancy visible on transvaginal ultrasound. NICE explicitly advises that serum hCG must not be used to determine location and that clinical symptoms outweigh the numerical result. Obtain two measurements approximately 48 hours apart. A rise over 63% makes a developing intrauterine pregnancy more likely and leads to a scheduled repeat scan, while ectopic pregnancy remains possible. A fall over 50% suggests a pregnancy unlikely to continue; less decisive change requires early-pregnancy review within the recommended timeframe.

Before radiology, surgery or potentially fetotoxic treatment, establish pregnancy possibility early enough to plan. A negative appropriately timed test can support proceeding, but a poorly timed negative must be identified as uncertain. Discuss imaging with radiology and use the examination that answers the urgent question with the lowest proportionate exposure; missing appendicitis, pulmonary embolism or intracranial disease also harms a pregnant patient. Do not substitute diagnostic delay for risk communication.

Confidentiality matters particularly for adolescents and coercive relationships. Assess competence or capacity, explain confidentiality limits and avoid automatically disclosing a result to parents or partners. Ask whether anyone controls contraception, pressures a pregnancy outcome or monitors records. If testing is declined, clarify the possible consequences, explore concerns, consider alternative management and document the informed choice. Emergency best-interests action during incapacity must be necessary and proportionate, not a routine exception to consent.

Key points

  • Base testing on whether pregnancy is biologically possible and clinically relevant, not on age, gender identity, relationship status, reported contraception or assumptions about sexual activity.
  • Explain why the result affects diagnosis, medicines, anaesthesia or imaging, seek consent and agree confidential communication; do not perform a hidden test simply because urine is available.
  • Home and clinical urine tests are most reliable from the first day of a missed period; if cycle timing is unknown, NHS advice is to test at least 21 days after the last unprotected sex.
  • A negative urine test may reflect testing too early, dilute urine, incorrect technique or reduced assay sensitivity; repeat with first-morning urine or obtain serum hCG when the consequence of missing pregnancy is high.
  • A positive urine or serum test does not locate the pregnancy. Pelvic pain, bleeding or risk factors require clinical assessment and usually transvaginal ultrasound through the early-pregnancy pathway.
  • For a pregnancy of unknown location, NICE advises two serum hCG measurements as close as possible to 48 hours apart and no earlier; interpret change only to plan follow-up, never to declare location.
  • An hCG rise greater than 63% over 48 hours suggests a developing intrauterine pregnancy but cannot exclude ectopic pregnancy; arrange the NICE-timed transvaginal scan and give symptom-led return advice.
  • If hCG falls by more than 50% over 48 hours, NICE supports follow-up testing as directed; a smaller fall or rise below 63% requires early clinical review because ectopic or failing pregnancy remains possible.
  • Urgent necessary imaging and treatment should be optimised for pregnancy but not withheld when delay poses greater harm; discuss radiation and medicine risk proportionately with the relevant specialist.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
High-risk symptom combinationRed flag

Amenorrhoea or an atypical period plus unilateral pain, bleeding, syncope or shoulder-tip pain warrants ectopic assessment even when reported contraception lowers probability.

Early false negative

Testing before expected menstruation or soon after intercourse can precede detectable urinary hCG; concentrated repeat urine or serum testing resolves clinically important uncertainty.

Pregnancy of unknown location

Positive hCG with no pregnancy visualised on transvaginal ultrasound is a temporary classification that requires symptom-led safety-netting, serial hCG and repeat imaging.

Persistent positive result

Recent birth, miscarriage, termination or hCG fertility medication can explain continuing detection, but an abnormal duration or symptoms require specialist assessment.

Coercive testing context

A partner demanding proof, obstructing testing or controlling the result may indicate reproductive coercion; speak with the patient alone and secure communications.

Test-treatment mismatch

A negative test that was taken too early cannot safely authorise a teratogenic medicine or dismiss pregnancy-related pain without further assessment.

Red flags requiring action

  • Pain, bleeding or haemodynamic change can precede a clearly positive urine result, so an early negative test does not close ectopic pregnancy when timing is uncertain.
  • A positive test establishes hCG exposure but not an intrauterine location, viable pregnancy or gestational age; ectopic risk remains until location is established.
  • Symptoms worsening during pregnancy-of-unknown-location follow-up require immediate review regardless of previous hCG trend or planned scan date.
  • Unexpected pregnancy testing in a child, possible exploitation, reproductive coercion or unsafe disclosure requires confidential safeguarding assessment and a protected contact plan.
  • Persistent hCG after pregnancy loss, termination or birth needs follow-up because retained pregnancy tissue, ectopic pregnancy or gestational trophoblastic disease may be responsible.
03Method and interpretationA systematic approach to the test and its findings.
Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

  1. 01
    Point-of-care urine hCGFirst step
    Why
    Rapidly identify pregnancy in acute or routine presentations where the result changes care.
    Interpretation and limitations
    Check device control, expiry, timing and sample concentration. A positive result does not locate pregnancy; an early negative can require repeat or serum testing.
  2. 02
    Quantitative serum hCG
    Why
    Detect lower concentrations and support follow-up when pregnancy location or persistence is uncertain.
    Interpretation and limitations
    Use serial values rather than one isolated number. NICE says hCG should not determine pregnancy location, and symptoms require review regardless of trend.
  3. 03
    Transvaginal ultrasound
    Why
    Assess pregnancy location, viability markers, adnexa and free fluid in early-pregnancy pain, bleeding or uncertain dating.
    Interpretation and limitations
    A non-diagnostic early scan creates a pregnancy-of-unknown-location pathway, not reassurance. Repeat timing follows symptoms and serial hCG-informed planning.
  4. 04
    Full blood count, group and rhesus status
    Why
    Assess bleeding impact and prepare safe treatment when haemorrhage or pregnancy loss is suspected.
    Interpretation and limitations
    Normal early haemoglobin cannot exclude acute blood loss. Crossmatch and resuscitation are driven by physiology; anti-D decisions follow current gestation and management guidance.
  5. 05
    Repeat urine test after timing interval
    Why
    Resolve a likely early negative when symptoms are stable and immediate serum testing is unnecessary.
    Interpretation and limitations
    Set an exact date and return precautions. NHS timing of 21 days after last unprotected intercourse is useful when the expected period is unknown.
  6. 06
    Histology or trophoblastic follow-up
    Why
    Investigate persistent hCG or abnormal bleeding after pregnancy when ordinary resolution has not occurred.
    Interpretation and limitations
    Trend and specialist pathway distinguish retained tissue, ectopic pregnancy and gestational trophoblastic disease; do not assume a new conception without dates and review.
04Clinical next stepsHow the result changes management or prompts escalation.
01First testEstablish timing, consent and consequenceFirst stepPregnancy could change the differential diagnosis, medicine, imaging or procedure.
  1. 1Ask privately about pregnancy potential, last normal period, cycle, contraception, sperm exposure, fertility treatment and recent pregnancy, then explain why testing matters.
  2. 2With consent, perform a correctly timed urine test; use serum hCG when urgent sensitivity or quantified follow-up is needed.
  3. 3Interpret the result against timing and symptoms, document limitations and ensure confidential result communication and follow-up ownership.
02Pain or bleedingLocate pregnancy and respond to physiologyA positive or uncertain test accompanies pelvic pain, bleeding, syncope or tenderness.
  1. 1Assess ABCDE and haemorrhage, involve urgent gynaecology care for instability or peritonism, and do not await serial tests before treating a suspected rupture.
  2. 2Arrange transvaginal ultrasound and quantitative hCG through the early-pregnancy service, with full blood count and blood preparation according to severity.
  3. 3If location is unknown, provide written symptom-led access, arrange two hCG measurements about 48 hours apart and schedule repeat scan or review from NICE criteria.
03Negative but uncertainDo not let assay timing overrule probabilityUrine testing is negative but exposure was recent or the presentation remains compatible with pregnancy.
  1. 1Confirm test timing, urine concentration, device technique and whether fertility treatment or irregular cycles alter interpretation.
  2. 2Use quantitative serum hCG now when delay is unsafe, or arrange a dated repeat urine test with first-morning sample when the patient is stable.
  3. 3Manage dangerous alternatives and provide urgent return advice; do not prescribe a high-risk medicine solely on an inadequately timed result.
04Persistent hCGDistinguish resolution, retained pregnancy and trophoblastic diseaseTesting remains positive after a recent pregnancy event or decline is slower than expected.
  1. 1Verify pregnancy dates, outcome, treatment, pathology and any exogenous hCG, and assess bleeding, pain, fever and haemodynamic status.
  2. 2Arrange serial quantitative hCG and ultrasound or specialist investigation under the relevant early-pregnancy or trophoblastic pathway.
  3. 3Track to documented resolution or diagnosis; worsening symptoms override a routine follow-up schedule.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
  • Record the date of last relevant intercourse or expected period, assay type, sample timing, result and whether the timing makes a negative result definitive or provisional.
  • For pregnancy of unknown location, trend symptoms first and hCG second, ensuring the patient has written 24-hour access instructions and a named early-pregnancy service.
  • Confirm that planned repeat hCG, urine testing or ultrasound occurs and that missed attendance triggers proportionate safe contact rather than silent closure.
  • After pregnancy loss or treatment, follow the specified test to resolution and escalate persistent positivity, increasing pain, fever, heavy bleeding or faintness.
  • Revisit confidentiality and communication safety when a pregnancy result could expose a young person or someone experiencing reproductive coercion.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Detected is not located

hCG proves neither an intrauterine sac nor viability; location remains a clinical and ultrasound question until directly established.

Timing creates sensitivity

A test can function correctly yet be clinically unhelpful when performed before enough hCG reaches urine, so dates belong beside every result.

Symptoms outrank curves

Even a reassuring hCG rise cannot make worsening unilateral pain or collapse safe; ectopic pregnancy remains possible until location is known.

Pregnancy risk is anatomical

Use relevant organs and sperm exposure rather than identity, appearance or relationship assumptions when deciding whether to offer testing.

Imaging risk is comparative

Pregnancy modifies protocol and consent, but the risk of radiation must be compared with harm from missing the urgent maternal diagnosis.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Accepting contraception, age or gender identity as proof that pregnancy testing has no relevance.

  2. 02

    Using one negative urine result obtained soon after intercourse to exclude an ectopic pregnancy.

  3. 03

    Interpreting a favourable hCG rise as confirmation that the pregnancy is intrauterine.

  4. 04

    Withholding urgent clinically necessary imaging because pregnancy status is positive or uncertain.

  5. 05

    Automatically sharing an adolescent’s result with a parent or a patient’s result with their partner.

  6. 06

    Closing follow-up after pregnancy loss before a required test demonstrates resolution.

Practice

Two practice questions

Question 1 of 20 correct
Obstetrics and gynaecologyOriginal SBA

Unknown location hCG rise

A stable patient with a pregnancy of unknown location has serum hCG measured twice 48 hours apart; it rises by 70%. There is no pain or bleeding. What is the best interpretation and next step?

Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom